Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-448.69% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BOLT · Sep 30, 2025
Bolt Biotherapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-25-277549General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
90.10% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-355.14% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
301.29% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
18.76% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesSelf-history eligible
Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/6 normalizedLevel 3Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20245/6 normalizedLevel 3Sep 30, 20245/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20254/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -531.98%
- Current
- -448.69%
- Delta
- 83.30%
- Previous
- 41.49%
- Current
- 90.10%
- Delta
- 48.61%
- Previous
- -510.53%
- Current
- -355.14%
- Delta
- 155.39%
- Previous
- 415.63%
- Current
- 301.29%
- Delta
- -114.34%
- Previous
- 34.65%
- Current
- 18.76%
- Delta
- -15.88%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BOLT Fundamental State →Analogous To · BOLT state analogue 4 →Transitioned To · BOLT Fundamental State →Transitioned To · BOLT CASH_GENERATION_INCREASED →Transitioned To · BOLT GROWTH_INCREASED →Transitioned To · BOLT PROFITABILITY_INCREASED →Transitioned To · BOLT R_AND_D_INTENSITY_DECREASED →Transitioned To · BOLT SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.